Filing Details
- Accession Number:
- 0001104659-21-151769
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-20 17:03:41
- Reporting Period:
- 2021-12-16
- Accepted Time:
- 2021-12-20 17:03:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1739426 | Osmotica Pharmaceuticals Plc | OSMT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1752153 | James Schaub | C/O Osmotica Pharmaceuticals Plc 400 Crossing Boulevard Bridgewater NJ 08807 | Evp And Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2021-12-16 | 93,800 | $1.07 | 405,900 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.05 to $1.08, inclusive. The Reporting Person undertakes to provide to Osmotica Pharmaceuticals plc, any security holder of Osmotica Pharmaceuticals plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.